148 related articles for article (PubMed ID: 26906551)
1. Pre-diagnostic serum levels of EGFR and ErbB2 and genetic glioma risk variants: a nested case-control study.
Späth F; Andersson U; Dahlin AM; Langseth H; Hovig E; Johannesen TB; Grankvist K; Björkblom B; Wibom C; Melin B
Tumour Biol; 2016 Aug; 37(8):11065-72. PubMed ID: 26906551
[TBL] [Abstract][Full Text] [Related]
2. A comprehensive study of the association between the EGFR and ERBB2 genes and glioma risk.
Andersson U; Schwartzbaum J; Wiklund F; Sjöström S; Liu Y; Tsavachidis S; Ahlbom A; Auvinen A; Collatz-Laier H; Feychting M; Johansen C; Kiuru A; Lönn S; Schoemaker MJ; Swerdlow AJ; Henriksson R; Bondy M; Melin B
Acta Oncol; 2010 Aug; 49(6):767-75. PubMed ID: 20446891
[TBL] [Abstract][Full Text] [Related]
3. Genetic risk variants in the CDKN2A/B, RTEL1 and EGFR genes are associated with somatic biomarkers in glioma.
Ghasimi S; Wibom C; Dahlin AM; Brännström T; Golovleva I; Andersson U; Melin B
J Neurooncol; 2016 May; 127(3):483-92. PubMed ID: 26839018
[TBL] [Abstract][Full Text] [Related]
4. Impact of EGFR genetic variants on glioma risk and patient outcome.
Costa BM; Viana-Pereira M; Fernandes R; Costa S; Linhares P; Vaz R; Pinheiro C; Lima J; Soares P; Silva A; Pardal F; Amorim J; Nabiço R; Almeida R; Alegria C; Pires MM; Pinheiro C; Carvalho E; Oliveira P; Lopes JM; Reis RM
Cancer Epidemiol Biomarkers Prev; 2011 Dec; 20(12):2610-7. PubMed ID: 21960689
[TBL] [Abstract][Full Text] [Related]
5. Serum levels of GFAP and EGFR in primary and recurrent high-grade gliomas: correlation to tumor volume, molecular markers, and progression-free survival.
Kiviniemi A; Gardberg M; Frantzén J; Parkkola R; Vuorinen V; Pesola M; Minn H
J Neurooncol; 2015 Sep; 124(2):237-45. PubMed ID: 26033547
[TBL] [Abstract][Full Text] [Related]
6. Epidermal growth factor receptor family (EGFR, ErbB2-4) in gliomas and meningiomas.
Andersson U; Guo D; Malmer B; Bergenheim AT; Brännström T; Hedman H; Henriksson R
Acta Neuropathol; 2004 Aug; 108(2):135-42. PubMed ID: 15148612
[TBL] [Abstract][Full Text] [Related]
7. A meta-analysis study of the association between EGFR rs2252586 mutation and the risk of glioma.
Xin Y; Han FG; Chen D; Chen J; Fang CX; Lou L; Liu H
Cell Mol Biol (Noisy-le-grand); 2017 Nov; 63(11):116-118. PubMed ID: 29208187
[TBL] [Abstract][Full Text] [Related]
8. EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) POLYMORPHIC VARIATIONS (-216G/T & -191 C/A) POSE A HIGH RISK TO PATIENTS WITH MALIGNANT GLIOMA.
Zahoor W; Pandith AA; Nisar S; Qasim I; Surana M; Ganie FA; Manzoor U; Arif SH; Rasool SUA; Lateef A; Shah P; Bhat RA
Exp Oncol; 2023 Oct; 45(2):203-210. PubMed ID: 37824771
[TBL] [Abstract][Full Text] [Related]
9. Investigation of established genetic risk variants for glioma in prediagnostic samples from a population-based nested case-control study.
Wibom C; Späth F; Dahlin AM; Langseth H; Hovig E; Rajaraman P; Johannesen TB; Andersson U; Melin B
Cancer Epidemiol Biomarkers Prev; 2015 May; 24(5):810-6. PubMed ID: 25713050
[TBL] [Abstract][Full Text] [Related]
10. Analysis of EGF+61A>G polymorphism and EGF serum levels in Brazilian glioma patients treated with perillyl alcohol-based therapy.
da Silveira Fd; Lopes Bde A; da Fonseca CO; Quirico-Santos T; de Palmer Paixão IC; de Amorim LM
J Cancer Res Clin Oncol; 2012 Aug; 138(8):1347-54. PubMed ID: 22481252
[TBL] [Abstract][Full Text] [Related]
11. Genes for epidermal growth factor receptor, transforming growth factor alpha, and epidermal growth factor and their expression in human gliomas in vivo.
Ekstrand AJ; James CD; Cavenee WK; Seliger B; Pettersson RF; Collins VP
Cancer Res; 1991 Apr; 51(8):2164-72. PubMed ID: 2009534
[TBL] [Abstract][Full Text] [Related]
12. Effect of epidermal growth factor receptor gene polymorphisms on prognosis in glioma patients.
Li B; Zhao W; Li J; Yan M; Xie Z; Zhu Y; Chen C; Jin T
Oncotarget; 2016 Sep; 7(39):63054-63064. PubMed ID: 27437777
[TBL] [Abstract][Full Text] [Related]
13. Pathological significance of epidermal growth factor receptor expression and amplification in human gliomas.
Zhao LL; Xu KL; Wang SW; Hu BL; Chen LR
Histopathology; 2012 Oct; 61(4):726-36. PubMed ID: 22978472
[TBL] [Abstract][Full Text] [Related]
14. EGFR gene variants are associated with specific somatic aberrations in glioma.
Wibom C; Ghasimi S; Van Loo P; Brännström T; Trygg J; Lau C; Henriksson R; Bergenheim T; Andersson U; Rydén P; Melin B
PLoS One; 2012; 7(12):e47929. PubMed ID: 23236348
[TBL] [Abstract][Full Text] [Related]
15. A novel functional polymorphism, 16974 A/C, in the interleukin-12-3' untranslated region is associated with risk of glioma.
Zhao B; Meng LQ; Huang HN; Pan Y; Xu QQ
DNA Cell Biol; 2009 Jul; 28(7):335-41. PubMed ID: 19435421
[TBL] [Abstract][Full Text] [Related]
16. Genetic variants in SLC7A7 are associated with risk of glioma in a Chinese population.
Fan S; Zhao Y; Li X; Du Y; Wang J; Song X; Zhou F; Chen H; Chen G; Zhao Y; Mao Y; Lan Q
Exp Biol Med (Maywood); 2013 Sep; 238(9):1075-81. PubMed ID: 23975734
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of serum extracellular vesicles as noninvasive diagnostic markers of glioma.
Wang H; Jiang D; Li W; Xiang X; Zhao J; Yu B; Wang C; He Z; Zhu L; Yang Y
Theranostics; 2019; 9(18):5347-5358. PubMed ID: 31410219
[No Abstract] [Full Text] [Related]
18. Downregulation of serum microRNA-205 as a potential diagnostic and prognostic biomarker for human glioma.
Yue X; Lan F; Hu M; Pan Q; Wang Q; Wang J
J Neurosurg; 2016 Jan; 124(1):122-8. PubMed ID: 26230475
[TBL] [Abstract][Full Text] [Related]
19. Two independent variants of epidermal growth factor receptor associated with risk of glioma in a Korean population.
Baek IK; Cheong HS; Namgoong S; Kim JH; Kang SG; Yoon SJ; Kim SH; Chang JH; Kim LH; Shin HD
Sci Rep; 2022 Nov; 12(1):19014. PubMed ID: 36347915
[TBL] [Abstract][Full Text] [Related]
20. Genetic variation in the EGFR gene and the risk of glioma in a Chinese Han population.
Hou WG; Ai WB; Bai XG; Dong HL; Li Z; Zhang YQ; Xiong LZ
PLoS One; 2012; 7(5):e37531. PubMed ID: 22662167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
